Subproject 4: Correlation between lumbar spinal performance and clinical outcomes after spine treatment in low back pain patients

Subproject 4: Correlation between lumbar spinal performance and clinical outcomes after spine treatment in low back pain patients - dyn3M - SP4

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029361

Enrollment

472

Registered

2022-06-29

Start date

2022-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-clinical population with chronic unspecific low back pain (LBP) and asymptomatic participants without LBP

Interventions

Group 1: WP1 has a cross-sectional design, WP2 and WP3 are designed longitudinal. In WP1 all participants will be asigned into two groups according to the inclusion criteria from dyn3m-SP1. Criterium

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • writen consent to participate in the study • asymptomatic (no LBP) and symptomatic (chronic LBP) caucasian women and men aged 18-64 years • Painduration >12 weeks • Pain localisation: lumbar pelvic region

Exclusion criteria

Exclusion criteria: • elite or professional athletes • acute infection • missuse of adictive substances • pregnancy • BMI > 28 kg/m2 • central or peripheral neurological disability • inflamatory or infected tissue in areas of interest (lower back) • fractures of the spine • osteoporosis • tumors or bone metastasis • former spine surgery • stong medical therapie (opioids, muscle relaxants, antiepileptika) • intake of longactive antihistaminika and/or systemic glukokortikoids and/or immune suppresing drugs • rheumatic diseases • active systemic diseases • internistic diseases that may cause risk for the participants during measurements and/or may influence diagnostic findings • erroneous posture or anaomaly of lower limbs • progressed disk herniation

Design outcomes

Primary

Measure	Time frame
The clinical parameter used to test the hypotheses are: ? strength of the extensor and flexor muscles ? neuromuscular control of spine stability ? specific muscle activation patterns (muscle synergies) ? low back pain intensity and disability	—

Secondary

Measure	Time frame
Lower back pain (questionnaire: adapt. von Korff pain scale; Von Korff et al., 1992) Pain grading lower back pain (questionnaire: adapt. von-Korff pain scale; Von Korff et al., 1992) lmpairment due to back pain (questionnaire: adapt. von Korff pain scale; Von Korff et al., 1992)	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026